INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 31 August 2015
Net Assets |
£238m |
Net Assets per share |
591p |
Share price |
551p |
Total value of unquoted investments |
£23m |
Total number of portfolio companies |
101 |
Top Ten Holdings
Company Name |
% NAV |
Celgene |
9.1 |
Gilead |
7.4 |
Regeneron |
7.1 |
Biogen |
5.1 |
Amgen |
4.9 |
Alexion |
4.6 |
Vertex |
3.9 |
Chimerix |
3.2 |
Incyte |
3.0 |
Biomarin |
3.0 |
|
----------- |
Total |
51.3 |
Portfolio Profitability |
% NAV |
Profitable |
54 |
Turning Profitable 2015 |
8 |
Unprofitable |
38 |
|
----------- |
Total |
100 |
Geographical Allocation |
% NAV |
US & Canada |
81 |
Europe & UK |
19 |
|
----------- |
Total |
100 |
Quoted/Unquoted Allocation |
% NAV |
Quoted |
91 |
Unquoted |
9 |
|
----------- |
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
23 SEPTEMBER 2015